Related references
Note: Only part of the references are listed.Clinicopathological factors associated with death from thin (≤ 1•00 mm) melanoma
M. Claeson et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis
L. Ny et al.
ACTA ONCOLOGICA (2020)
Histologic and Phenotypic Factors and MC1R Status Associated with BRAFV600E, BRAFV600K, and NRAS Mutations in a Community-Based Sample of 414 Cutaneous Melanomas
Elke Hacker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival
Rachel M. Cymerman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival
Rachel M. Cymerman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
David C. Whiteman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Nevus-Associated Melanomas: Clinicopathologic Features
Danielle Shitara et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia
Adele C. Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database
John F. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cellular cohesion as a prognostic factor in malignant melanoma: a retrospective study with up to 12 years follow-up
Ioannis Roxanis et al.
MODERN PATHOLOGY (2010)
Share Paper
